Clinical Trial Update: Single Dose Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Evaluation of Eplivanserin in Children With Insomnia [Phase 1]

View source ↗

Summary

Phase 1 study in children with insomnia evaluating the safety, tolerability, and pharmacokinetic/pharmacodynamic profile of a single dose of eplivanserin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Eplivanserin (Eplivanserin)

Snippet

Sponsor: Sanofi | Conditions: Sleep Initiation and Maintenance Disorders | Phase 1 | Status: COMPLETED